| Literature DB >> 33519439 |
Xionghua Sun1, Mei Zhu1, Xihua Chen1, Xiaogang Jiang1.
Abstract
Previous cDNA microarray results showed that MYH9 gene expression levels are increased in TGF-β1-stimulated lung fibroblast. Recently, our proteomic results revealed that the expression levels of MYH9 protein are notably upregulated in lung tissues of bleomycin-treated rats. However, whether MYH9 plays a critical role in the differentiation of fibroblast remains unclear. Herein, we demonstrated that TGF-β1 increased MYH9 expression, and siRNA-mediated knockdown of MYH9 and pharmacological inhibition of MYH9 ATPase activity remarkably repressed TGF-β1-induced lung fibroblast-to-myofibroblast differentiation. TGF-β1-stimulated MYH9 induction might be via ALK5/Smad2/3 pathway but not through noncanonical pathways, including p38 mitogen-activated kinase, and Akt pathways in lung fibroblasts. Our results showed that MYH9 inhibition suppressed TGF-β1-induced lung fibroblast-to-myofibroblast differentiation, which provides valuable information for illuminating the pathological mechanisms of lung fibroblast differentiation, and gives clues for finding new potential target for pulmonary fibrosis treatment.Entities:
Keywords: MYH9; Smad2/3; TGF– β1; lung fibroblast; pulmonary fibrosis
Year: 2021 PMID: 33519439 PMCID: PMC7838063 DOI: 10.3389/fphar.2020.573524
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810